FindAPhD Weekly PhD Newsletter | JOIN NOW FindAPhD Weekly PhD Newsletter | JOIN NOW

4 Year PhD with Integrated MSc in Neuroscience: ApoE-ε4 induced blood-brain barrier dysfunction in Alzheimer’s disease


   Department of Neuroscience


About the Project

Background:

Blood-brain barrier dysfunction in Alzheimer’s Disease (AD)

The blood-brain barrier (BBB) is formed by a continuous layer of cerebral endothelial cells held together by tight junction proteins (TJP), which restrict the movement of molecules. BBB dysfunction is an early biomarker of cognitive impairment, occurring during the early clinical stages of AD [1]. Loss of TJP expression and breakdown of the BBB is associated with the accumulation of serum proteins normally excluded from the CNS, which may stimulate a neuroinflammatory response and further contribute to disease pathogenesis [2].

ApoE-ε4 induced BBB dysfunction

Possession of one or two ApoE-ε4 alleles is a major risk factor for developing AD, and leads to accelerated breakdown of the BBB [3]. Magnetic resonance imaging studies have shown that individuals with at least one ε4 allele display more BBB dysfunction in the hippocampus and temporal cortex than those without an ε4 allele [1]. Furthermore, dysfunction of the BBB is detected in cognitively normal individuals who possess an ε4 allele, and more severe in those with cognitive impairment [1], however the mechanism(s) underlying this dysfunction is currently unknown.

miRNAs impact BBB integrity

microRNAs (miRNAs) are small, non-coding RNAs which target molecules in a sequence-specific manner to modulate messenger RNA (mRNA) expression. miRNAs are linked to pathologically relevant mechanisms, including BBB dysfunction [4]. We have previously characterised the detailed neuropathology of an ageing cohort and demonstrated BBB dysfunction in the normal ageing process [5], and assessed age-associated changes in the transcriptomic and miR profile of the neurovascular unit, identifying biologically relevant age-associated RNA changes which impact BBB function and modulate the neuroinflammatory response [6]. Similar detailed studies in AD are required, as the modulation of miRNA expression represents a potential therapeutic strategy for restoring BBB integrity in AD.

We hypothesise that ApoE-ε4 induced miRNA/mRNA network changes impact BBB integrity and contribute to cognitive decline in AD. The proposed study aims to identify the potential mechanism(s) underlying ApoE-ε4 associated vascular pathology in AD. Specifically, this study aims to  

  1. Histologically assess BBB dysfunction in control and AD cases, both with and without ApoE-ε4
  2. Characterise ApoE-ε4 associated miRNA and mRNA changes in the BBB using RNAseq
  3. Interrogate the bioinformatic datasets to identify biologically relevant miRNA and mRNA candidates, and validate the findings both at the protein level (by immunohistochemistry) and RNA (by digital PCR)

This study will provide a greater understanding of the ApoE-ε4 induced mRNA/miRNA network changes that occur and may help to develop novel therapies to restore BBB integrity in AD.


Funding Notes

Funding:
This project is suitable for a self-funded student or a student with a government scholarship including from overseas.
Entry Requirements:
Candidates must have a first or upper second class honours degree or significant research experience.
How to apply:
Please complete a University Postgraduate Research Application form available here: View Website
Please clearly state the prospective main supervisor in the respective box and select Department of Neuroscience as the department.
Enquiries:
Interested candidates should in the first instance contact Dr Julie Simpson ()

References

Nature 581(7806) 71-76.
[2] M.D. Sweeney et al. (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders, Nat Rev Neurol 14(3) 133-150.
[3] Y. Yamazaki et al. (2019) Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies, Nat Rev Neurol 15(9) 501-518.
[4] S. Swarbrick et al. (2019) Systematic Review of miRNA as Biomarkers in Alzheimer's Disease, Mol Neurobiol 56(9) 6156-6167.
[5] E.F. Goodall et al. (2018) Age-associated changes in the blood brain barrier: Comparative studies in human and mouse. NAN 44(3):328-340
[6] E.F. Goodall et al. (2019) mRNA and miRNA expression changes at the neurovascular unit reveal a role for autophagy and DNA binding in the cerebral microvasculature of the ageing brain. Int J Mol Sci 20(12) pii: E3097.

Email Now


PhD saved successfully
View saved PhDs